ISPE Congress on Innovation

Plant Tours

Wednesday 9 April 2008

Description:

This session offers you the unique opportunity to visit one of three pharmaceutical facilities in Denmark.

Novo Nordisk A/S
Hillerød, Denmark
www.novonordisk.com

Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.

Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.

H. Lundbeck A/S
Copenhagen Valby, Denmark
www.lundbeck.com

H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders.

H Lundbeck A/S has more than 50 years of experience in research, development, production, marketing and sale of pharmaceuticals for the treatment of diseases of the central nervous system (CNS).

Lundbeck aims to continue to develop new and innovative pharmaceuticals to help people who suffer from CNS diseases.

The ISPE plant tour will include an overview of Lundbeck, our innovative pharmaceutical products and our production. In addition we’ll present how we manage the cultural change of implementing LEAN and Quality by Design (QbD).

Biogen Idec Inc.
Hillerød, Denmark
www.biogenidec.com

Biogen Idec was formed in 2003 from the merger of two of the world's leading biotechnology companies, Biogen, Inc and IDEC Pharmaceuticals Corporation. The site in Hilleroed, Denmark, is mainly a packaging facility but with a significant expansion activity ongoing.

The company is one of a handful of biotechnology companies that has three licensed and dedicated biological bulk-manufacturing facilities, including one of the world's largest cell culture facilities.

Take Back to Your Job

• View world-class facilities
• Share best practice and knowledge
• Network with colleagues
• Benchmark your own operations

Agenda:

Coaches for the plant venues will depart from the Congress venue at 13.30, and are expected to return at 17.00.


Congress Programme General Information Hotel Information Networking Evening Sponsorship Opportunities Table Top Exhibitions Registration Information Download Brochure	ISPE Congress on Innovation Plant Tours Wednesday 9 April 2008 Description: This session offers you the unique opportunity to visit one of three pharmaceutical facilities in Denmark. Novo Nordisk A/S Hillerød, Denmark www.novonordisk.com Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. H. Lundbeck A/S Copenhagen Valby, Denmark www.lundbeck.com H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. H Lundbeck A/S has more than 50 years of experience in research, development, production, marketing and sale of pharmaceuticals for the treatment of diseases of the central nervous system (CNS). Lundbeck aims to continue to develop new and innovative pharmaceuticals to help people who suffer from CNS diseases. The ISPE plant tour will include an overview of Lundbeck, our innovative pharmaceutical products and our production. In addition we’ll present how we manage the cultural change of implementing LEAN and Quality by Design (QbD). Biogen Idec Inc. Hillerød, Denmark www.biogenidec.com Biogen Idec was formed in 2003 from the merger of two of the world's leading biotechnology companies, Biogen, Inc and IDEC Pharmaceuticals Corporation. The site in Hilleroed, Denmark, is mainly a packaging facility but with a significant expansion activity ongoing. The company is one of a handful of biotechnology companies that has three licensed and dedicated biological bulk-manufacturing facilities, including one of the world's largest cell culture facilities. Take Back to Your Job • View world-class facilities • Share best practice and knowledge • Network with colleagues • Benchmark your own operations Agenda: Coaches for the plant venues will depart from the Congress venue at 13.30, and are expected to return at 17.00.